Clinical trial
Pharmacokinetic, Safety and Efficacy Study of a Six-Month Depot Formulation of Leuprolide in Subjects With Prostatic Carcinoma
NCT00056654 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacokinetic, Safety and Efficacy Study of a Six-Month Depot Formulation of Leuprolide in Subjects With Prostatic Carcinoma
- Lead sponsor
- Abbott
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2003
- Completion date
- July 31, 2004
- Enrollment
- 164 (actual)
- Sites
- 55
Conditions
As the registry lists them; a condition with its own page is linked.